Innovative Approaches to Investigating KRAS Therapeutics with Biochemical Cell-Based Assays

Kirsten rat sarcoma viral oncogene homologue (KRAS) is the most frequently mutated oncogene, present in approximately 25% of tumors. Numerous studies on KRAS in the initiation and advancement of cancer are constantly updating our knowledge of the gene...